Jeff Hanke is currently Vice President of AstraZeneca Cancer Discovery at AstraZeneca R&D, in Boston, MA, where he and his team of researchers focus on novel approaches to cancer therapy. Dr. Hanke joined AstraZeneca from Pfizer, where he managed discovery teams in the areas of immunology, inflammation, allergy/respiratory, and cancer from 1993 to 1999. In addition, Dr. Hanke helped to establish Pfizer's Discovery Technology Center, located in Cambridge, Mass., which focuses on applying new technologies to drug discovery. Dr. Hanke received his M.S. in Biology from Fordham University, and his Ph.D. in 1986 from Baylor College of Medicine. He completed his post-doctoral training at Southwestern Medical School in Dallas.
